| pubmed-article:12006518 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12006518 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:12006518 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:12006518 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12006518 | lifeskim:mentions | umls-concept:C0079459 | lld:lifeskim |
| pubmed-article:12006518 | lifeskim:mentions | umls-concept:C0246415 | lld:lifeskim |
| pubmed-article:12006518 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
| pubmed-article:12006518 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:12006518 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:12006518 | pubmed:dateCreated | 2002-5-13 | lld:pubmed |
| pubmed-article:12006518 | pubmed:abstractText | A multicenter Phase II trial was performed to investigate the efficacy and tolerance of combined docetaxel and gemcitabine +/- recombinant human granulocyte colony-stimulating factor (G-CSF) in patients with metastatic breast cancer. | lld:pubmed |
| pubmed-article:12006518 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12006518 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12006518 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12006518 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12006518 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12006518 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12006518 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12006518 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12006518 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12006518 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12006518 | pubmed:month | May | lld:pubmed |
| pubmed-article:12006518 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:12006518 | pubmed:author | pubmed-author:ScheithauerWe... | lld:pubmed |
| pubmed-article:12006518 | pubmed:author | pubmed-author:KornekGabriel... | lld:pubmed |
| pubmed-article:12006518 | pubmed:author | pubmed-author:RadererMarkus... | lld:pubmed |
| pubmed-article:12006518 | pubmed:author | pubmed-author:SchüllBirgitB | lld:pubmed |
| pubmed-article:12006518 | pubmed:author | pubmed-author:LangFritzF | lld:pubmed |
| pubmed-article:12006518 | pubmed:author | pubmed-author:DepischDieter... | lld:pubmed |
| pubmed-article:12006518 | pubmed:author | pubmed-author:KovatsErwinE | lld:pubmed |
| pubmed-article:12006518 | pubmed:author | pubmed-author:HaiderKarinK | lld:pubmed |
| pubmed-article:12006518 | pubmed:author | pubmed-author:KwasnyWernerW | lld:pubmed |
| pubmed-article:12006518 | pubmed:author | pubmed-author:PayritsThomas... | lld:pubmed |
| pubmed-article:12006518 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12006518 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:12006518 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12006518 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12006518 | pubmed:pagination | 1051-6 | lld:pubmed |
| pubmed-article:12006518 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:meshHeading | pubmed-meshheading:12006518... | lld:pubmed |
| pubmed-article:12006518 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12006518 | pubmed:articleTitle | Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor. | lld:pubmed |
| pubmed-article:12006518 | pubmed:affiliation | Department of Internal Medicine I, Division of Oncology, Vienna University Medical School, Waehringer Guertel 18-20, A-1090 Vienna. gabriela.kornek@akh-wien.ac.at | lld:pubmed |
| pubmed-article:12006518 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12006518 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12006518 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:12006518 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:12006518 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12006518 | lld:pubmed |
